Melissa K Accordino
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer (NCT02632045) | Melissa K Accordino | 2016-03-01 |
Track Melissa K Accordino automatically
Every clearance here is in the API, with alerts when new ones post.